Cancers of the gallbladder and biliary ducts.

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Neoplasms of the biliary tract tree are uncommon and have a poor overall prognosis. Although numerous risk factors have been identified, little is known about the pathogenesis of these tumors, and no effective screening technique is available for early detection. Surgery remains the principal treatment modality and the only potential cure, with laparoscopy playing an increasingly important role in determining the resectability of these tumors. The role of postoperative adjuvant chemotherapy and radiation remains controversial. The efficacy of chemotherapy for advanced disease is relatively limited, with response rates of less than 10% for single-agent fluorouracil. Of the newer agents, gemcitabine (Gemzar) holds the most promise in the treatment of these difficult malignancies.

Original languageEnglish (US)
Pages (from-to)939-946, 949
JournalOncology (Williston Park, N.Y.)
Volume16
Issue number7
StatePublished - Jul 2002

Fingerprint

Gallbladder Neoplasms
gemcitabine
Neoplasms
Biliary Tract
Adjuvant Chemotherapy
Fluorouracil
Laparoscopy
Radiation
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Cancers of the gallbladder and biliary ducts. / Yee, Kevin; Sheppard, Brett; Domreis, John; Blanke, Charles.

In: Oncology (Williston Park, N.Y.), Vol. 16, No. 7, 07.2002, p. 939-946, 949.

Research output: Contribution to journalArticle

@article{006cd59393bf4bc19fac7fcb75cf4c2f,
title = "Cancers of the gallbladder and biliary ducts.",
abstract = "Neoplasms of the biliary tract tree are uncommon and have a poor overall prognosis. Although numerous risk factors have been identified, little is known about the pathogenesis of these tumors, and no effective screening technique is available for early detection. Surgery remains the principal treatment modality and the only potential cure, with laparoscopy playing an increasingly important role in determining the resectability of these tumors. The role of postoperative adjuvant chemotherapy and radiation remains controversial. The efficacy of chemotherapy for advanced disease is relatively limited, with response rates of less than 10{\%} for single-agent fluorouracil. Of the newer agents, gemcitabine (Gemzar) holds the most promise in the treatment of these difficult malignancies.",
author = "Kevin Yee and Brett Sheppard and John Domreis and Charles Blanke",
year = "2002",
month = "7",
language = "English (US)",
volume = "16",
pages = "939--946, 949",
journal = "ONCOLOGY (United States)",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "7",

}

TY - JOUR

T1 - Cancers of the gallbladder and biliary ducts.

AU - Yee, Kevin

AU - Sheppard, Brett

AU - Domreis, John

AU - Blanke, Charles

PY - 2002/7

Y1 - 2002/7

N2 - Neoplasms of the biliary tract tree are uncommon and have a poor overall prognosis. Although numerous risk factors have been identified, little is known about the pathogenesis of these tumors, and no effective screening technique is available for early detection. Surgery remains the principal treatment modality and the only potential cure, with laparoscopy playing an increasingly important role in determining the resectability of these tumors. The role of postoperative adjuvant chemotherapy and radiation remains controversial. The efficacy of chemotherapy for advanced disease is relatively limited, with response rates of less than 10% for single-agent fluorouracil. Of the newer agents, gemcitabine (Gemzar) holds the most promise in the treatment of these difficult malignancies.

AB - Neoplasms of the biliary tract tree are uncommon and have a poor overall prognosis. Although numerous risk factors have been identified, little is known about the pathogenesis of these tumors, and no effective screening technique is available for early detection. Surgery remains the principal treatment modality and the only potential cure, with laparoscopy playing an increasingly important role in determining the resectability of these tumors. The role of postoperative adjuvant chemotherapy and radiation remains controversial. The efficacy of chemotherapy for advanced disease is relatively limited, with response rates of less than 10% for single-agent fluorouracil. Of the newer agents, gemcitabine (Gemzar) holds the most promise in the treatment of these difficult malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0036654841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036654841&partnerID=8YFLogxK

M3 - Article

C2 - 12164560

AN - SCOPUS:0036654841

VL - 16

SP - 939-946, 949

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 7

ER -